PRP for Frontal Fibrosing Alopecia

Recruiting in Palo Alto (17 mi)

Overseen ByRonda Farah, MD

Age: 18+

Sex: Any

Travel: May be covered

Time Reimbursement: Varies

Trial Phase: Academic

Waitlist Available

Sponsor: University of Minnesota

No Placebo Group

Approved in 2 jurisdictions

Trial Summary

What is the purpose of this trial?This trial is testing a treatment called platelet rich plasma (PRP) to help people with frontal fibrosing alopecia, a type of hair loss. PRP is made from a person's own blood and injected into the scalp to promote hair growth and reduce symptoms. The study will last several months and includes multiple treatment visits and follow-ups. PRP therapy is a new procedure used to treat various types of hair loss by promoting hair growth.

Eligibility Criteria

This trial is for adults with frontal fibrosing alopecia, who can consent and follow the study rules. They must not be pregnant or breastfeeding, avoid certain medications and supplements, use specific shampoo, and agree to contraception if applicable. People with scalp atrophy, severe allergies, bleeding disorders or on certain treatments are excluded.

Inclusion Criteria

I am willing to only use the hair/scalp products provided by the study.

My scalp biopsy confirmed I have frontal fibrosing alopecia.

I am able to understand and agree to the study's procedures and risks.

Exclusion Criteria

I am currently on medication that weakens my immune system.

I am currently undergoing chemotherapy or radiation.

I currently have cancer.

I have taken medication like hydroxychloroquine or prednisone in the last 3 months.

I have a problem with how my blood clots.

I have HIV, a connective tissue disorder, PCOS, or untreated thyroid disease.

My scalp is thinning.

I have a blood or bleeding disorder.

Participant Groups

The trial tests platelet rich plasma (PRP) prepared using Eclipse Easy Spin centrifuge for treating frontal fibrosing alopecia. PRP will be injected into the affected scalp area to see if it reduces symptoms and promotes hair growth.

1Treatment groups

Experimental Treatment

Group I: Eclipse Easy Spin for PRP TreatmentExperimental Treatment1 Intervention

Assessing the safety and efficacy of platelet rich plasma for treating frontal fibrosing alopecia. This will be accomplished by the production of platelet rich plasma by the Eclipse Easy Spin centrifuge. Subjects will receive treatment once a month for 6 months. Platelet rich plasma will be administered via injections into the affected areas of the scalp.

Platelet Rich Plasma is already approved in United States, European Union for the following indications:

🇺🇸 Approved in United States as Platelet Rich Plasma for: